Accueil/Actions/LXRX

LXRX

USD

Lexicon Pharmaceuticals Inc. Common Stock

$1.340+0.010 (0.752%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$1.330

Haut

$1.390

Bas

$1.325

Volume

2.72M

Fondamentaux de l'Entreprise

Capitalisation Boursière

487.0M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

2.36M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.28Actuel $1.340Haut $1.66

Actualités Connexes

4 nov. 2025 · 13:30

GlobeNewswire

Data Demonstrating Unique Benefits of Sotagliflozin in Diverse Patient Populations will be Presented at the Hypertrophic Cardiomyopathy Society and American Heart Association's Sessions 2025 in New Orleans

THE WOODLANDS, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that data from three studies of sotagliflozin will be presented during upcoming medical meetings. Two

Data Demonstrating Unique Benefits of Sotagliflozin in Diverse Patient Populations will be Presented at the Hypertrophic Cardiomyopathy Society and American Heart Association's Sessions 2025 in New Orleans

30 oct. 2025 · 12:30

GlobeNewswire

Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

THE WOODLANDS, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced the Company will release its third quarter 2025 financial results on Thursday, November 6, 2025, prior